Accounting for Equity Considerations in Cost-Effectiveness Analysis: A Systematic Review of Rotavirus Vaccine in Low- and Middle-Income Countries

Marie-Anne Boujaoude; Andrew Mirelman; Kim  Dalziel; Natalie Carvalho

doi:10.1186/s12962-018-0102-2

Accounting for Equity Considerations in Cost-Effectiveness Analysis: A Systematic Review of Rotavirus Vaccine in Low- and Middle-Income Countries

Marie-Anne Boujaoude, Andrew Mirelman, Kim Dalziel, Natalie Carvalho

Centre for Health Economics

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1-14
Number of pages	14
Journal	Cost Effectiveness and Resource Allocation
Volume	16
Issue number	18
DOIs	https://doi.org/10.1186/s12962-018-0102-2
Publication status	Published - 18 May 2018

Bibliographical note

Keywords

VACCINE
EQUITY
Systematic review
Cost effectiveness
LMIC

Access to Document

10.1186/s12962-018-0102-2Licence: CC BY

document-1
© The Author(s) 2018.
Final published version, 1.61 MBLicence: CC BY

Cite this

@article{1aa2e6e139574872a830d208d172d09c,

title = "Accounting for Equity Considerations in Cost-Effectiveness Analysis: A Systematic Review of Rotavirus Vaccine in Low- and Middle-Income Countries",

keywords = "VACCINE, EQUITY, Systematic review, Cost effectiveness, LMIC",

author = "Marie-Anne Boujaoude and Andrew Mirelman and Kim Dalziel and Natalie Carvalho",

note = "{\textcopyright} The Author(s) 2018.",

year = "2018",

month = may,

day = "18",

doi = "10.1186/s12962-018-0102-2",

language = "English",

volume = "16",

pages = "1--14",

journal = "Cost Effectiveness and Resource Allocation",

publisher = "BioMed Central",

number = "18",

}

TY - JOUR

T1 - Accounting for Equity Considerations in Cost-Effectiveness Analysis

T2 - A Systematic Review of Rotavirus Vaccine in Low- and Middle-Income Countries

AU - Boujaoude, Marie-Anne

AU - Mirelman, Andrew

AU - Dalziel, Kim

AU - Carvalho, Natalie

PY - 2018/5/18

Y1 - 2018/5/18

KW - VACCINE

KW - EQUITY

KW - Systematic review

KW - Cost effectiveness

KW - LMIC

U2 - 10.1186/s12962-018-0102-2

DO - 10.1186/s12962-018-0102-2

M3 - Article

VL - 16

SP - 1

EP - 14

JO - Cost Effectiveness and Resource Allocation

JF - Cost Effectiveness and Resource Allocation

IS - 18

ER -